AKI Therapeutics A/S — Credit Rating and Financial Key Figures

CVR number: 37509736
Slotsmarken 12, 2970 Hørsholm

Income statement (kDKK)

2016
2017
2018
2019
Fiscal period length12121212
Net sales
Gross profit-6.65-4.00-4.60- 128.66
Total depreciation-8.09
EBIT-6.65-12.09-4.60- 128.66
Other financial income50.00
Other financial expenses-0.92-1.31-1.31-0.24
Pre-tax profit-7.56-13.40-5.91-78.90
Income taxes1.3021.55
Net earnings-7.56-13.40-4.61-57.35

Assets (kDKK)

2016
2017
2018
2019
Development expenditure8.097.34122.69473.48
Intangible assets total8.097.34122.69473.48
Tangible assets total
Investments total
Long term receivables total
Inventories total
Current other receivables2.222.0917.9366.75
Current deferred tax assets1.3069.85
Short term receivables total2.222.0919.23136.60
Cash and bank deposits37.9424.612.38233.81
Cash and cash equivalents37.9424.612.38233.81
Balance sheet total (assets)48.2534.04144.30843.89

Equity and liabilities (kDKK)

2016
2017
2018
2019
Share capital50.0050.0050.0050.00
Other reserves247.65
Retained earnings-7.56-20.96- 273.25
Profit of the financial year-7.56-13.40-4.61-57.35
Shareholders equity total42.4429.0324.43-32.95
Provisions48.32
Non-current other liabilities288.56
Non-current liabilities total288.56
Current trade creditors74.88534.00
Current owed to participating40.00288.56
Other non-interest bearing current liabilities5.815.005.00- 282.62
Current liabilities total5.815.00119.88539.95
Balance sheet total (liabilities)48.2534.04144.30843.89
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.